Cucurbitacin-I inhibits Aurora kinase A, Aurora kinase B and survivin, induces defects in cell cycle progression and promotes ABT-737-induced cell death in a caspase-independent manner in malignant human glioma cells
Authors:
- Daniel R PremkumarDPDaniel R Premkumar
- Esther P JaneEJEsther P Jane
- Ian F PollackIPIan F Pollack
- 21 November 2014
- journal article
- Published by Taylor & Francis in Cancer Biology & Therapy
- Vol. 16 (2) , 233-243
Abstract
Because STAT signaling is commonly activated in malignant gliomas as a result of constitutive EGFR activation, strategies for inhibiting the EGFR/JAK/STAT cascade are of significant interest. We, therefore, treated a panel of established glioma cell lines, including EGFR overexpressors, and primary cultures derived from patients diagnosed with glioblastoma with the JAK/STAT inhibitor cucurbitacin-I. Treatment with cucurbitacin-I depleted p-STAT3, p-STAT5, p-JAK1 and p-JAK2 levels, inhibited cell proliferation, and induced G2/M accumulation, DNA endoreduplication, and multipolar mitotic spindles. Longer exposure to cucurbitacin-I significantly reduced the number of viable cells and this decrease in viability was associated with cell death, as confirmed by an increase in the subG1 fraction. Our data also demonstrated that cucurbitacin-I strikingly downregulated Aurora kinase A, Aurora kinase B and survivin. We then searched for agents that exhibited a synergistic effect on cell death in combination with cucurbitacin-I. We found that cotreatment with cucurbitacin-I significantly increased Bcl(-)2/Bcl(-)xL family member antagonist ABT-737-induced cell death regardless of EGFR/PTEN/p53 status of malignant human glioma cell lines. Although >50% of the cucurbitacin-I plus ABT-737 treated cells were annexin V and propidium iodide positive, PARP cleavage or caspase activation was not observed. Pretreatment of z-VAD-fmk, a pan caspase inhibitor did not inhibit cell death, suggesting a caspase-independent mechanism of cell death. Genetic inhibition of Aurora kinase A or Aurora kinase B or survivin by RNA interference also sensitized glioma cells to ABT-737, suggesting a link between STAT activation and Aurora kinases in malignant gliomas.Keywords
This publication has 80 references indexed in Scilit:
- Mitotic catastrophe and cell death induced by depletion of centrosomal proteinsCell Death & Disease, 2013
- ABT-737 promotes tBid mitochondrial accumulation to enhance TRAIL-induced apoptosis in glioblastoma cellsCell Death & Disease, 2012
- Identification of Chemosensitivity Nodes for Vinblastine through Small Interfering RNA High-Throughput ScreensThe Journal of Pharmacology and Experimental Therapeutics, 2011
- Analysis of Phosphotyrosine Signaling in Glioblastoma Identifies STAT5 as a Novel Downstream Target of ΔEGFRJournal of Proteome Research, 2011
- Nuclear trafficking of the epidermal growth factor receptor family membrane proteinsOncogene, 2010
- Identification of a PTEN-regulated STAT3 brain tumor suppressor pathwayGenes & Development, 2008
- Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumorsInternational Journal of Pharmaceutics, 2008
- Stat3 activation in human endometrial and cervical cancersBritish Journal of Cancer, 2007
- The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralizedCancer Cell, 2006
- STATs in oncogenesisOncogene, 2000